Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
Svenningsson A, Frisell T, Burman J, Salzer J, Fink K, Hallberg S, Hambraeus J, Axelsson M, Nimer FA, Sundström P, Gunnarsson M, Johansson R, Mellergård J, Rosenstein I, Ayad A, Sjöblom I, Risedal A, de Flon P, Gilland E, Lindeberg J, Shawket F, Piehl F, Lycke J. Svenningsson A, et al. Among authors: mellergard j. Lancet Neurol. 2022 Aug;21(8):693-703. doi: 10.1016/S1474-4422(22)00209-5. Lancet Neurol. 2022. PMID: 35841908 Clinical Trial.
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Longinetti E, Bower H, McKay KA, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Piehl F, Frisell T. Longinetti E, et al. Among authors: mellergard j. Ann Clin Transl Neurol. 2022 Sep;9(9):1449-1458. doi: 10.1002/acn3.51646. Epub 2022 Aug 22. Ann Clin Transl Neurol. 2022. PMID: 35993445 Free PMC article.
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis.
Tedeholm H, Piehl F, Lycke J, Link J, Stawiarz L, Burman J, de Flon P, Fink K, Gunnarsson M, Mellergård J, Nilsson P, Sundström P, Svenningsson A, Johansson H, Andersen O. Tedeholm H, et al. Among authors: mellergard j. Mult Scler Relat Disord. 2022 Dec;68:104220. doi: 10.1016/j.msard.2022.104220. Epub 2022 Oct 5. Mult Scler Relat Disord. 2022. PMID: 36242804 Free article.
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.
Englund S, Kierkegaard M, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Longinetti E, Frisell T, Piehl F. Englund S, et al. Among authors: mellergard j. Mult Scler Relat Disord. 2023 Feb;70:104481. doi: 10.1016/j.msard.2022.104481. Epub 2022 Dec 23. Mult Scler Relat Disord. 2023. PMID: 36603296 Free article.
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.
Longinetti E, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould AM, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Piehl F, Frisell T. Longinetti E, et al. Among authors: mellergard j. J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):134-141. doi: 10.1136/jnnp-2023-331784. J Neurol Neurosurg Psychiatry. 2024. PMID: 37558400 Free PMC article.
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
Silfverberg T, Zjukovskaja C, Ljungman P, Nahimi A, Ahlstrand E, Dreimane A, Einarsdottir S, Fagius J, Iacobaeus E, Hägglund H, Lange N, Lenhoff S, Lycke J, Mellergård J, Piehl F, Svenningsson A, Tolf A, Cherif H, Carlson K, Burman J. Silfverberg T, et al. Among authors: mellergard j. J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):125-133. doi: 10.1136/jnnp-2023-331864. J Neurol Neurosurg Psychiatry. 2024. PMID: 37748927 Free PMC article.
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis.
Åkesson J, Hojjati S, Hellberg S, Raffetseder J, Khademi M, Rynkowski R, Kockum I, Altafini C, Lubovac-Pilav Z, Mellergård J, Jenmalm MC, Piehl F, Olsson T, Ernerudh J, Gustafsson M. Åkesson J, et al. Among authors: mellergard j. Nat Commun. 2023 Oct 30;14(1):6903. doi: 10.1038/s41467-023-42682-9. Nat Commun. 2023. PMID: 37903821 Free PMC article.
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.
Papapavlou Lingehed G, Hellberg S, Huang J, Khademi M, Kockum I, Carlsson H, Tjernberg I, Svenvik M, Lind J, Blomberg M, Vrethem M, Mellergård J, Gustafsson M, Jenmalm MC, Olsson T, Ernerudh J. Papapavlou Lingehed G, et al. Among authors: mellergard j. Front Immunol. 2022 Jul 29;13:930947. doi: 10.3389/fimmu.2022.930947. eCollection 2022. Front Immunol. 2022. PMID: 35967338 Free PMC article.
22 results